SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-127754
Filing Date
2020-04-30
Accepted
2020-04-30 08:24:12
Documents
5
Period of Report
2020-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d871135d8k.htm 8-K 31799
2 EX-23.1 d871135dex231.htm EX-23.1 1545
3 EX-99.1 d871135dex991.htm EX-99.1 25733
4 EX-99.2 d871135dex992.htm EX-99.2 1247025
5 EX-99.3 d871135dex993.htm EX-99.3 48024
  Complete submission text file 0001193125-20-127754.txt   1355257
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 20833286
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences